Clik here to view.
エリテック、米国で新たな特許が付与されたと発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は、アスパラギナーゼの分野で新たな特許が米国で付与されたことを発表します。 特許（WO 2010/052315...
View ArticleClik here to view.
Aortic Valve Stenosis Treatment in Thailand by Phyathai 2 International Hospital
BANGKOK Phyathai 2 International Hospital’s Heart Center uses the latest techniques and technology available to investigate any heart conditions and provide the best treatment for patients of all...
View ArticleClik here to view.
The Region Zealand Gives Top Priority to Staff Safety in New Hospital
GOTHENBURG, Sweden With an investment of more than DKK 4 million, Zealand has opted for a thoroughly tested alarm solution from the leading supplier in this field, Ascom, which also stands behind...
View ArticleClik here to view.
Gynesonics Receives FDA Approval to Commence a Pivotal IDE Clinical Trial for...
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has received...
View ArticleClik here to view.
Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to...
CAMBRIDGE, Mass. & SHANGHAI Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX) today announced a collaboration to offer Foundation Medicine’s comprehensive...
View ArticleClik here to view.
Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman...
SALISBURY, England & BEIJING Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd....
View ArticleClik here to view.
Enigma Diagnostics与北京利德曼生化股份有限公司签署合资协议，并宣布一项5000万美元的投资
英格兰索尔兹伯里和北京 (美国商业资讯) — 分子诊断床边(point-of-care)感染性疾病检测的全球领先者Enigma Diagnostics Ltd (Enigma)与北京利德曼生化股份有限公司（Beijing Leadman Biochemistry Co.,...
View ArticleClik here to view.
HCL Technologies Achieves Life Sciences Competency Status in the AWS Partner...
SUNNYVALE, Calif. & NOIDA, India HCL Technologies, a leading global IT services company, announced today that it has acquired the status of Life Sciences Competency by Amazon Web Services (AWS)....
View ArticleClik here to view.
Xagenic 任命 Timothy I. Still 为总裁兼首席执行官
多伦多 (美国商业资讯) — Xagenic是一家分子诊断公司，开发首个无需实验室、20分钟即可得出结果的分子诊断平台。公司今天宣布，任命Timothy I. Still为总裁兼首席执行官。Still先生同时兼任Xagenic Inc.董事会成员。 Still先生最近的职务是Accumetrics...
View ArticleClik here to view.
Xagenic がティモシー・I・スティルを社長兼最高経営責任者に任命
トロント (ビジネスワイヤ） — 分子診断分野の企業として、20分で結果が得られる初のラボ不要分子診断プラットフォームを開発中のXagenicは本日、ティモシー・I・スティルを社長兼最高経営責任者（CEO）に任命したと発表しました。スティルはXagenic Inc.の取締役会にも加わることになります。...
View ArticleClik here to view.
A Novel Lectin Was Isolated by the Research Team of Jinchi Biotech Ltd. (JBL)
ZHANGJIAJIE, China Lately, Andrias Davidianus Lectin (ADL) was isolated successfully from the body-surface mucus of Andrias Davidianus (Giant Salamander) by JBL Research Team who had done 3 years of...
View ArticleClik here to view.
ChinaBio® Partnering Forum 2015 to be held in Shanghai, China April 22–23, 2015
CARLSBAD, Calif. & SHANGHAI The 2015 edition of ChinaBio® Partnering Forum, China’s premier life science partnering event, will be held April 22–23 in Shanghai. Shanghai is the largest city...
View ArticleClik here to view.
Akebia Announces Positive Top-Line Results from its Phase 2b Study of...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia...
View ArticleClik here to view.
ZRG Partners Life Sciences Hiring Index Shows Double Digit Increases Over 2013
WEST ORANGE, N.J. ZRG Partners, Inc. announces the results of its third quarter Global Life Sciences Hiring Index. The Index posts its highest score in nearly five years, even with the European...
View ArticleClik here to view.
Cardiovascular Systems Enrolls First Seven Patients in Japan for Coast Study
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study....
View ArticleClik here to view.
EOS imaging Obtains Marketing Approval in South Korea
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, today announced that the Company has received approval from the Korean Food and Drug...
View ArticleClik here to view.
BioNet Appoints New COO and Accelerates the Development of New Recombinant...
BANGKOK BioNet-Asia, a vaccine company focused on vaccine discovery and supply, announced that Georges Thiry has been appointed COO of the company, effective early 2015. “Georges Thiry’s invaluable...
View ArticleClik here to view.
KineMed和美国陆军宣布合作测量军事行动中的肌肉功能和反应
加州爱莫利维尔 (美国商业资讯)–KineMed, Inc.和美国陆军环境医学研究所(USARIEM)的军事营养部今天宣布，双方缔结一项伙伴关系，以探寻采用KineMed的平台技术来评估参战者的骨骼肌蛋白质合成和肌肉质量。 美国军方寻求更加透彻地了解肌肉对军事行动压力源的适应性反应，以便找到促进骨骼肌健康和快速恢复能力的营养要求和策略。KineMed首席执行官兼董事长David...
View ArticleClik here to view.
PharmAbcine Announces Global Licensing Deal with Triphase Accelerator...
DAEJEON, Korea, TORONTO & SAN DIEGO PharmAbcine, a private biotechnology company focused on the discovery and development of novel bi-specific antibodies, today announced a new global licensing...
View ArticleClik here to view.
Cerus Announces Agreement With Kawasumi Laboratories for the Development of...
CONCORD, Calif. Cerus Corporation (NASDAQ: CERS) announced today that it has entered into a partnership agreement with Kawasumi Laboratories to develop an INTERCEPT platelet kit designed for use in...
View Article